Akoya Biosciences, Inc.

NasdaqGS:AKYA Stock Report

Market Cap: US$188.1m

Akoya Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:AKYA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Sep 23BuyUS$92,014Frederic PlaIndividual20,000US$4.60
12 Jun 23BuyUS$600,000Robert SheplerIndividual120,000US$5.00
12 Jun 23BuyUS$1,016,940Matthew WinklerIndividual203,388US$5.00
12 Jun 23BuyUS$100,000Scott MendelIndividual20,000US$5.00
12 Jun 23BuyUS$100,000Myla Lai-GoldmanIndividual20,000US$5.00
12 Jun 23BuyUS$100,000John EkIndividual20,000US$5.00
12 Jun 23BuyUS$10,000,000Telegraph Hill PartnersCompany2,000,000US$5.00
12 Jun 23BuyUS$100,000Thomas RaffinIndividual20,000US$5.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of AKYA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies10,4080.0212%
Individual Insiders2,780,7125.66%
Hedge Funds4,697,7859.56%
General Public7,284,00814.8%
Institutions10,098,01620.5%
VC/PE Firms24,269,80249.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 28.6%.


Top Shareholders

Top 25 shareholders own 82.28% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
36%
Telegraph Hill Partners
17,675,247US$67.7m0%56.72%
9.56%
Blue Water Life Science Advisors, LP
4,697,785US$18.0m0%18.46%
7.16%
PS Capital Partners, LLC
3,517,360US$13.5m29.4%no data
6.26%
aMoon Fund
3,077,195US$11.8m5.44%14.61%
3.21%
Polar Capital Holdings Plc
1,579,756US$6.0m0%0.03%
2.87%
The Vanguard Group, Inc.
1,408,157US$5.4m4.28%no data
2.79%
BlackRock, Inc.
1,372,232US$5.3m-5.04%no data
2%
Matthew Winkler
984,513US$3.8m0%no data
1.37%
Parkman Healthcare Partners LLC
674,787US$2.6m28.4%0.36%
1.37%
Uniplan Investment Counsel, Inc.
673,523US$2.6m21.5%0.21%
1.26%
Stanford Management Company
620,433US$2.4m0%0.15%
1.26%
Garry Nolan
616,913US$2.4m0%no data
1.05%
SVB Wealth LLC
515,317US$2.0m0%0.04%
1.01%
Geode Capital Management, LLC
498,175US$1.9m6.89%no data
0.75%
Robert Shepler
369,592US$1.4m0%no data
0.73%
State Street Global Advisors, Inc.
357,591US$1.4m-0.12%no data
0.59%
Peddock Capital Advisors, LLC
290,720US$1.1m546%0.31%
0.53%
Joseph Driscoll
262,500US$1.0m0%no data
0.48%
Thomas Raffin
234,592US$898.2k0%no data
0.45%
Northern Trust Global Investments
219,676US$841.0k19.6%no data
0.42%
Charles Schwab Investment Management, Inc.
204,849US$784.3k0%no data
0.32%
Millennium Management LLC
157,368US$602.5k-71%no data
0.32%
Schonfeld Strategic Advisors LLC
155,800US$596.5k20.3%no data
0.29%
Niro Ramachandran
144,799US$554.4k5.03%no data
0.26%
Osterweis Capital Management, Inc.
126,131US$482.9k0%0.03%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.